Lusefi Indications/Uses


Taisho Pharmaceutical


Zuellig Pharma
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Lusefi is indicated in the treatment of type 2 diabetes mellitus to improve glycemic control in adults as: Monotherapy: When diet and exercise alone do not provide adequate glycemic control in patients for whom use of metformin is considered inappropriate due to intolerance.
Add-on combination therapy: In combination with glucose-lowering medicinal products including insulin preparations in adult patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise plus monotherapy does not provide adequate glycemic control. (For study results with respect to combinations and effects on glycemic control see Pharmacology: Pharmacodynamics: CLINICAL STUDIES: Add-on combination therapy under Actions).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in